Improved sensitivity to insulin in obese subjects following weight loss is accompanied by reduced protein-tyrosine phosphatases in adipose tissue.

Insulin resistance in adipose tissue in human obesity is associated with increased protein-tyrosine phosphatase (PTPase) activity and elevated levels of the PTPases leukocyte common antigen-related PTPase (LAR) and PTP1B. To determine whether the improved insulin sensitivity associated with weight loss in obese subjects is accompanied by reversible changes in PTPases, we obtained subcutaneous adipose tissue from seven obese subjects (mean body mass index [BMI], 40.4 kg/m2) before and after a loss of 10% of body weight and again after a 4-week maintenance period. Weight loss was accompanied by an 18.5% decrease in overall adipose tissue PTPase activity (P = .015) that was further reduced to 22.3% of the control value (P = .005) at the end of the maintenance period. By immunoblot analysis, the abundance of LAR was decreased by 21% (P = .04) and abundance of PTP1B was decreased by 40% (P < .004) after the initial weight loss, and the decreases persisted during the maintenance period. Enhanced insulin sensitivity following weight loss, evident from a 26% decrease in fasting insulin levels (P < .05), was also closely correlated with the reduction in the abundance of both LAR (R2 = .80, P < .01) and PTP1B (R2 = .64, P = .03). These results support the hypothesis that LAR and PTP1B may be reversibly involved in the pathogenesis of insulin resistance, and may be therapeutic targets in insulin-resistant states.

[1]  E. Harlow,et al.  Antibodies: A Laboratory Manual , 1988 .

[2]  Jerrold M. Olefsky,et al.  Protein-tyrosine Phosphatase 1B Is a Negative Regulator of Insulin- and Insulin-like Growth Factor-I-stimulated Signaling* , 1996, The Journal of Biological Chemistry.

[3]  E. Krebs,et al.  Effect of microinjection of a low-Mr human placenta protein tyrosine phosphatase on induction of meiotic cell division in Xenopus oocytes , 1990, Molecular and cellular biology.

[4]  B. Goldstein,et al.  Insulin receptor and epidermal growth factor receptor dephosphorylation by three major rat liver protein-tyrosine phosphatases expressed in a recombinant bacterial system. , 1992, The Biochemical journal.

[5]  B. Goldstein,et al.  Insulin Receptor Signaling Is Augmented by Antisense Inhibition of the Protein Tyrosine Phosphatase LAR (*) , 1995, The Journal of Biological Chemistry.

[6]  E. Volpi,et al.  Contribution of obesity to insulin resistance in noninsulin-dependent diabetes mellitus. , 1995, The Journal of clinical endocrinology and metabolism.

[7]  R. Mooney,et al.  Phosphorylation of the insulin receptor in permeabilized adipocytes is coupled to a rapid dephosphorylation reaction. , 1989, The Journal of biological chemistry.

[8]  J. Olefsky.  Decreased insulin binding to adipocytes and circulating monocytes from obese subjects. , 1976, The Journal of clinical investigation.

[9]  B. Goldstein,et al.  Insulin receptor protein-tyrosine phosphatases. Leukocyte common antigen-related phosphatase rapidly deactivates the insulin receptor kinase by preferential dephosphorylation of the receptor regulatory domain. , 1992, The Journal of biological chemistry.

[10]  E. Krebs,et al.  A comparison of the insulin- and epidermal growth factor-stimulated protein kinases from human placenta. , 1984, Journal of Biological Chemistry.

[11]  C. Kahn,et al.  Metabolic effects of sodium metavanadate in humans with insulin-dependent and noninsulin-dependent diabetes mellitus in vivo and in vitro studies. , 1995, The Journal of clinical endocrinology and metabolism.

[12]  W. Pories,et al.  Insulin-Receptor Kinase Activity of Adipose Tissue From Morbidly Obese Humans With and Without NIDDM , 1987, Diabetes.

[13]  A. Shisheva,et al.  The protein tyrosine phosphatase inhibitor, pervanadate, is a powerful antidiabetic agent in streptozotocin-treated diabetic rats. , 1994, Endocrinology.

[14]  Goldstein Bj.  Regulation of insulin receptor signaling by protein-tyrosine dephosphorylation. , 1993 .

[15]  H. Shamoon,et al.  Oral vanadyl sulfate improves hepatic and peripheral insulin sensitivity in patients with non-insulin-dependent diabetes mellitus. , 1995, The Journal of clinical investigation.

[16]  B. Goldstein,et al.  Purification, identification and subcellular distribution of three predominant protein-tyrosine phosphatase enzymes in skeletal muscle tissue. , 1995, Biochimica et biophysica acta.

[17]  B. Goldstein,et al.  Suppression of insulin receptor activation by overexpression of the protein-tyrosine phosphatase LAR in hepatoma cells. , 1996, Cellular signalling.

[18]  J. Friedman,et al.  Restoration of insulin responsiveness in skeletal muscle of morbidly obese patients after weight loss. Effect on muscle glucose transport and glucose transporter GLUT4. , 1992, The Journal of clinical investigation.

[19]  C. Kahn,et al.  Vanadate normalizes hyperglycemia in two mouse models of non-insulin-dependent diabetes mellitus. , 1991, The Journal of clinical investigation.

[20]  J. Meyerovitch,et al.  Osmotic Loading of Neutralizing Antibodies Demonstrates a Role for Protein-tyrosine Phosphatase 1B in Negative Regulation of the Insulin Action Pathway (*) , 1995, The Journal of Biological Chemistry.

[21]  R. Considine,et al.  A new technique for biopsy of human abdominal fat under local anaesthesia with Lidocaine. , 1994, International journal of obesity and related metabolic disorders : journal of the International Association for the Study of Obesity.

[22]  W. Pories,et al.  Cellular alterations in liver, skeletal muscle, and adipose tissue responsible for insulin resistance in obesity and type II diabetes. , 1989, Diabetes/metabolism reviews.

[23]  Human placenta protein-tyrosine-phosphatase: amino acid sequence and relationship to a family of receptor-like proteins , 1989 .

[24]  D. D. Shock,et al.  Dynamic regulation of intact and C-terminal truncated insulin receptor phosphorylation in permeabilized cells. , 1994, Biochemistry.

[25]  J. Gerich,et al.  Impact of obesity on insulin action in volunteers with normal glucose tolerance: demonstration of a threshold for the adverse effect of obesity. , 1990, The Journal of clinical endocrinology and metabolism.

[26]  H. Klein,et al.  Decreased kinase activity of insulin receptors from adipocytes of non-insulin-dependent diabetic subjects. , 1987, The Journal of clinical investigation.

[27]  N. Tonks,et al.  Purification of protein-tyrosine phosphatases from human placenta. , 1991, Methods in enzymology.

[28]  J. Caro.  Clinical review 26: Insulin resistance in obese and nonobese man. , 1991, The Journal of clinical endocrinology and metabolism.

[29]  R. Henry,et al.  Skeletal muscle protein tyrosine phosphatase activity and tyrosine phosphatase 1B protein content are associated with insulin action and resistance. , 1994, The Journal of clinical investigation.

[30]  R. Considine,et al.  Serum immunoreactive-leptin concentrations in normal-weight and obese humans. , 1996, The New England journal of medicine.

[31]  B. Goldstein,et al.  Increased abundance of the receptor-type protein-tyrosine phosphatase LAR accounts for the elevated insulin receptor dephosphorylating activity in adipose tissue of obese human subjects. , 1995, The Journal of clinical investigation.

[32]  U. K. Laemmli,et al.  Cleavage of Structural Proteins during the Assembly of the Head of Bacteriophage T4 , 1970, Nature.

[33]  J. Olefsky,et al.  Mechanisms of insulin resistance in human obesity: evidence for receptor and postreceptor defects. , 1980, The Journal of clinical investigation.

[34]  J. Olefsky,et al.  Reversibility of defective adipocyte insulin receptor kinase activity in non-insulin-dependent diabetes mellitus. Effect of weight loss. , 1988, The Journal of clinical investigation.

[35]  S. Brichard,et al.  The role of vanadium in the management of diabetes. , 1995, Trends in pharmacological sciences.

[36]  A. Ullrich,et al.  Selective Down-regulation of the Insulin Receptor Signal by Protein-tyrosine Phosphatases α and ε (*) , 1995, The Journal of Biological Chemistry.

[37]  J. Olefsky,et al.  Insulin action kinetics in adipocytes from obese and noninsulin-dependent diabetes mellitus subjects: identification of multiple cellular defects in glucose transport. , 1991, The Journal of clinical endocrinology and metabolism.

[38]  B. Goldstein.  Protein‐Tyrosine phosphatases and the regulation of insulin action , 1992, Journal of cellular biochemistry.

[39]  A. Ullrich,et al.  Differential activities of protein tyrosine phosphatases in intact cells. , 1993, The Journal of biological chemistry.

[40]  M. M. Bradford.  A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. , 1976, Analytical biochemistry.

[41]  C. Kahn,et al.  The insulin signaling system. , 1994, The Journal of biological chemistry.

[42]  D. Rabinowitz.  Some endocrine and metabolic aspects of obesity. , 1970, Annual review of medicine.

[43]  G. Boden,et al.  Effects of Age and Body Fat Insulin Resistance in Healthy Men , 1993, Diabetes Care.

[44]  E. Krebs,et al.  Microinjection of a protein-tyrosine-phosphatase inhibits insulin action in Xenopus oocytes. , 1990, Proceedings of the National Academy of Sciences of the United States of America.

[45]  B. Goldstein,et al.  Alterations in specific protein-tyrosine phosphatases accompany insulin resistance of streptozotocin diabetes. , 1995, The American journal of physiology.

[46]  K. Flegal,et al.  Increasing Prevalence of Overweight Among US Adults: The National Health and Nutrition Examination Surveys, 1960 to 1991 , 1994 .

[47]  H. Towbin,et al.  Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: procedure and some applications. , 1979, Proceedings of the National Academy of Sciences of the United States of America.

[48]  I. G. Fantus,et al.  Peroxovanadium compounds. A new class of potent phosphotyrosine phosphatase inhibitors which are insulin mimetics. , 1994, The Journal of biological chemistry.